Description

Dezloratadin (Desloratadine) Syrup 0.5 mg/ml. 60 ml

Ingredients

Active ingredient: Desloratadine
Other ingredients: Purified water, sorbitol solution, propylene glycol, citric acid, sodium citrate, sucralose, natural and artificial flavor, and sodium benzoate.

Dosage

Adults and children over 12 years: 10 ml once daily.
Children 6-12 years: 5 ml once daily.
Do not exceed the recommended dosage.

Indications

Dezloratadin syrup is indicated for the relief of symptoms associated with allergic rhinitis and chronic idiopathic urticaria.

Contraindications

Do not use Dezloratadin syrup if you are allergic to desloratadine or any of the other ingredients in the syrup. Consult a healthcare provider before use if pregnant or breastfeeding.

Directions

Shake well before use. Use the provided measuring device to ensure the correct dosage. Can be taken with or without food.

Scientific Evidence

Desloratadine, the active ingredient in Dezloratadin syrup, is a selective H1-antihistamine that effectively blocks histamine receptors, providing relief from allergy symptoms. Studies have shown that desloratadine is non-sedating and well-tolerated, making it a preferred choice for long-term management of allergic conditions.

Additional Information

It is important to store Dezloratadin syrup at room temperature away from moisture and heat. Keep out of reach of children. If you miss a dose, take it as soon as you remember. However, if it is almost time for the next dose, skip the missed dose and continue with the regular dosing schedule.

Pharmacological Effects: Desloratadine works by selectively blocking H1 receptors, thereby inhibiting the action of histamine. This action helps in reducing the symptoms of allergic reactions, such as itching, sneezing, and runny nose.

Clinical Trials: Clinical trials have demonstrated the efficacy of desloratadine in providing relief from allergic rhinitis and chronic idiopathic urticaria with minimal side effects. A study published in the Journal of Allergy and Clinical Immunology showed that desloratadine significantly improved quality of life measures in patients with allergic rhinitis.